Mark Hindle is a highly experienced analytical chemist in Pharmaceutical R&D, currently serving as the Director of CMC Regulatory Affairs at AstraZeneca. With a career spanning several decades, they have specialized in regulatory writing, interactions with healthcare authorities, and analytical method transfer. Hindle has successfully led analytical preparations for numerous regulatory submissions and is recognized for their contributions to Quality by Design (QbD) approaches in drug development. They hold a BSc in Chemistry from Loughborough University, having graduated in 1982.
This person is not in any teams
This person is not in any offices